Main description:

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This updated volume discusses topics such as clinical and safety assessment of HCC patients, liver transplantation as a therapeutic option, immunotherapy interventions, and image-based surveillance. In addition, it discusses immunohistology of HCC-enabled precision medicine and artificial intelligence for hepatocellular carcinomas.

This is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.

Contents:

1. Clinical and safety assessment of the HCC patients
2. Liver transplantation for HCC therapy
3. Clinical trials for HCC in the diagnosis and therapy: An international perspective
4. Recent advancements in immunotherapy interventions for the management of HCC
5. Role of genetic insights and tumor microenvironment in HCC: New opportunities for gene therapy
6. An Update on the treatment of hepatocellular carcinoma
7. An update of image-based surveillance in HCC
8. Meta-analysis of PD-1/PD-L1 inhibitors in advanced HCC
9. Towards a personalized medicine approach for the treatment of HCC
10. Precision medicine in the theranostics of HCC
11. Immunohistology of HCC-enabled precision medicine
12. Artificial Intelligence and Precision Medicine for HCC
13. Genomics-Enabled Precision Medicine for HCC